# Semaglutide Treatment in Young Adults Living With Type 2 Diabetes: A Post Hoc Analysis From the SUSTAIN and PIONEER Clinical Trials.

> PubMed lists PMID 41994903 in Diabetes, obesity & metabolism as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2026-04-17 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-41994903-semaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-26
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41994903-semaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41994903-semaglutide-v1.json
- Content SHA-256: `4300f4c4d22583efe4baebcb8f30edea7186144c60f4ce1aa38b8c7888192a48`

## Claims and source pins

### Headline

Semaglutide Treatment in Young Adults Living With Type 2 Diabetes: A Post Hoc Analysis From the SUSTAIN and PIONEER Clinical Trials. ([`pubmed-observation-pmid-41994903-2026-07-26-e594bc768391`](#source-pubmed-observation-pmid-41994903-2026-07-26-e594bc768391))

### Summary

PubMed lists PMID 41994903 in Diabetes, obesity & metabolism as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2026-04-17 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41994903-2026-07-26-e594bc768391`](#source-pubmed-observation-pmid-41994903-2026-07-26-e594bc768391))

### Paragraph 1

PubMed lists PMID 41994903 in Diabetes, obesity & metabolism as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2026-04-17 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41994903-2026-07-26-e594bc768391`](#source-pubmed-observation-pmid-41994903-2026-07-26-e594bc768391))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41994903-2026-07-26-e594bc768391`](#source-pubmed-observation-pmid-41994903-2026-07-26-e594bc768391))

## Sources

<a id="source-pubmed-observation-pmid-41994903-2026-07-26-e594bc768391"></a>
- **Semaglutide Treatment in Young Adults Living With Type 2 Diabetes: A Post Hoc Analysis From the SUSTAIN and PIONEER Clinical Trials. · retained source version 1:2026-07-26:current:e594bc76839100b1f0657dc359621e707f00b1ed715392107f51cc07f26ba667** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41994903/) (`pubmed-observation-pmid-41994903-2026-07-26-e594bc768391`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Semaglutide Treatment in Young Adults Living With Type 2 Diabetes: A Post Hoc Analysis From the SUSTAIN and PIONEER Clinical Trials." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41994903-semaglutide-v1.json SHA-256: 4300f4c4d22583efe4baebcb8f30edea7186144c60f4ce1aa38b8c7888192a48.